Updates in the Treatment and Prevention of C. difficile: Hospital Perspectives

This CME activity addresses hospital perspectives on C. difficile infection such as surveillance, preventive strategies and tailoring therapy to disease severity and patient factors. In this video-based interview, two faculty will discuss their approaches to the prevention and management of CDI and recurrent CDI in the hospital setting. This is the third in a series of five educational activities on CDI to be released in 2017.

This activity is intended for gastroenterologists, infectious disease specialists, and other healthcare professionals that treat C. difficile infections.

Upon completion of this activity, participants will be able to:
• Summarize the epidemiology of C. difficile infections in hospital settings
• Identify patients who may be at increased risk for C. difficile infection
• Discuss strategies for preventing the transmission of C. difficile in hospitalized patients
• Outline evidence-based approaches for the management of initial and recurrent episodes of C. difficile

Clostridium difficile infection (CDI) is associated with significant morbidity and mortality. Further, recurrence of CDI is common after an initial episode. Although a number of therapies with varying mechanisms of action are available to treat CDI and prevent recurrence, the management of recurrent CDI is complex and challenging. Clinicians require up-to-date knowledge on evidence-based treatment of recurrent CDI to reduce its burden and improve clinical outcomes.

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.